Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention
September 11, 2018
In this program, experts James Underberg, MD, MS (Chair), Alan Brown, MD, Peter Jones, MD, and Pamela Morris, MD present compelling presentations and cases focusing on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention.
CME 0.00 Credits
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
CME 2.00 Credits
Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series
January 01, 2018
An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol
CME 1.50 Credits
LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS
April 08, 2017
In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.
No Credit Available
Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment
April 29, 2015
Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.
No Credit Available